“Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases”. Hematology Meeting Reports 2, no. 6 (June 23, 2009). Accessed June 3, 2026. https://journals.pagepress.net/hmr/article/view/771.